| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 173.773 | 82 |
| GSM780708 | Untreated after 4 days (C2_1) | 156.565 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 156.462 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 171.785 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 184.837 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 147.235 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 152.802 | 81 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 162.509 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 185.4 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 155.507 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 169.391 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 206.198 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 148.058 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 135.055 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 174.334 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 152.229 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 168.917 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 138.713 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 200.695 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 156.403 | 81 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 181.486 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 175.796 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 197.669 | 83 |